Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Mallinckrodt
Accenture
Harvard Business School
Healthtrust
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Queensland Health
US Army

Generated: August 17, 2017

DrugPatentWatch Database Preview

PERTZYE Drug Profile

« Back to Dashboard

What is the patent landscape for Pertzye, and what generic Pertzye alternatives are available?

Pertzye is a drug marketed by Digestive Care Inc and is included in one NDA.

The generic ingredient in PERTZYE is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for Tradename: PERTZYE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list2
Drug Prices:see details
DailyMed Link:PERTZYE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-001May 17, 2012RXYesNo► Subscribe► Subscribe► Subscribe
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-002May 17, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Digestive Care Inc
PERTZYE
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022175-003Oct 6, 2016RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Farmers Insurance
Cantor Fitzgerald
AstraZeneca
Queensland Health
Baxter
Julphar
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot